封面
市场调查报告书
商品编码
1836822

腹膜透析市场(按产品类型、治疗领域、应用和最终用户)—2025-2032 年全球预测

Peritoneal Dialysis Market by Product Type, Therapeutic Area, Application, End User - Global Forecast 2025-2032

出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年腹膜透析市场将成长至 158.3 亿美元,复合年增长率为 6.09%。

主要市场统计数据
基准年2024年 98.6亿美元
预计2025年 104.3亿美元
预测年份:2032年 158.3亿美元
复合年增长率(%) 6.09%

对不断发展的护理模式、技术进步和临床重点的基础概述重塑了临床和家庭环境中腹膜透析的提供

腹膜透析仍然是肾臟替代疗法中重要的治疗方法,这得益于患者人口结构的变化、治疗偏好的演变以及持续的技术进步。在过去十年中,临床医生和医疗系统越来越认识到腹膜透析在支持居家医疗、减轻住院负担和提供以患者为中心的自主治疗方面的潜力。这种转变得益于技术创新,包括自动週期计、改进的溶液生物相容性以及整合的远端监控功能,从而降低了门诊管理的门槛。

因此,从设备和解决方案製造相关人员到透析服务提供者和付款方,利害关係人正在重新评估临床通讯协定、供应链和培训模式,以适应不断发展的实践模式。临床医生专注于保护腹膜功能并简化治疗方法以提高依从性,而医疗系统则强调基于价值的成果和营运效率。因此,产品蓝图和策略性投资越来越重视耐用性、连接性和易用性。本概述为重点讨论影响腹膜透析应用和创新的驱动因素、阻碍因素和策略槓桿奠定了基础。

自动化、溶液化学、远端监控和政策奖励的进步如何重新定义腹膜透析护理模式和供应重点

由于技术、医疗服务和政策的融合,腹膜透析领域正在发生重大变化。在技​​术方面,自动化正在从基本的週期计功能发展到智慧系统,该系统可以减少手动步骤,并透过调度、警报和远端资料传输来支援依从性。同时,溶液化学正在朝着减少腹膜压力和併发症风险的配方发展,从而延长治疗时间。

同时,医疗服务模式正朝向去中心化转变。越来越多的患者在家中接受系统性远距临床监督。这种转变刺激了对远端医疗的投资——支持监控、整合供应物流和病患教育平台。儘管一些司法管辖区正在调整政策和报销框架以奖励居家治疗,但支付方仍然存在差异性。最后,近期的市场波动使供应链韧性和供应商多元化成为策略重点,迫使製造商重新评估采购、合约条款和近岸外包选项。这些转变既为製造商、医疗保健提供者和医疗系统带来了差异化机会,也带来了新的营运挑战。

评估不断变化的采购动态和製造商策略,以因应 2025 年影响成本、采购和服务连续性的关税变化

2025年新关税的出台,为腹膜透析相关人员的采购和供应链规划带来了额外的复杂性。进口耗材和资本设备的关税上调,给依赖全球采购透析袋、连接器和週期计组件的供应商和製造商的成本结构带来了压力。为此,一些供应商正在加速製造地的多元化,优先考虑关键原材料的在地采购,并重新考虑其供应商整合策略,以减轻贸易政策波动的影响。

这些发展也促使卫生系统和采购团体重新协商长期供应协议,将关税差异条款纳入合同,并评估总到岸成本而非仅仅评估单位成本。同时,人们也越来越关注国内製造能力和战略储备,以缓衝未来的关税波动。监管机构和付款人越来越关注成本压力如何影响医疗服务的取得和使用模式,并由此引发了围绕报销调整和基于价值的合约的对话。因此,采购环境变得更加复杂,营运敏捷性、情境规划和供应商生态系统的韧性对于维持腹膜透析服务的连续性至关重要。

深度细分洞察,将产品系列、治疗适应症、临床用途和最终用户需求与策略重点连结起来

透过对产品、疗法、应用和最终用户细分的洞察,揭示了腹膜透析生态系统中存在的差异化机会和限制因素。产品类型包括腹膜透析液袋、引流袋、腹膜透析导管套件和转运套件等配件;腹膜透析设备,例如自动腹膜透析週期计和连续性可携式腹膜透析设备;以及腹膜透析溶液,例如生物相容性溶液、葡萄糖溶液和低葡萄糖溶液。这些产品差异直接影响采购週期、临床训练需求和资本投资决策;耗材影响反覆出现的物流优先顺序;设备则影响临床工作流程的重新设计。

从治疗角度来看,我们关注的是急性肾损伤、慢性肾臟病和郁血性心臟衰竭等患者群体,每种疾病都有其独特的临床病程和使用模式,这会影响设备选择和解决方案的选择。从应用角度来看,管理糖尿病肾臟病、肾丝球肾炎、狼疮性肾炎和多囊性肾病变等病因需要量身定制的临床方案和独特的监测策略。最终用户范围广泛,从透析中心到家庭医疗保健项目再到医院,每种环境对员工培训、库存管理和远端支援都有不同的要求。整合这些细分视角,可以为确定研发、商业管道和临床证据产生的优先顺序提供详细的视图。

比较区​​域付款人框架、临床实践差异和製造地如何影响全球腹膜透析市场的采用和获取

腹膜透析的前景在很大程度上受到技术应用、监管环境和医疗服务模式等区域动态的影响。在美洲,临床医生和医疗服务提供者正在平衡对家庭治疗的强烈临床兴趣与主导对稳健疗效和成本控制的迫切需求,这为将改善患者体验与显着降低医院利用率相结合的价值提案创造了肥沃的土壤。某些市场的监管明确性和完善的报销机制正在加速腹膜透析的采用,但各国支付方之间存在差异。

欧洲、中东和非洲的情况各不相同。西方市场正在推动先进临床通讯协定与远端医疗的整合,而其他地区则面临基础设施限制和耗材取得不均等的困境。该地区的政策制定者和医疗保健系统越来越重视供应链的韧性和公平获取,从而推动了创新官民合作关係的建立。在亚太地区,慢性肾臟病的快速增长伴随着医疗保健基础设施的不断扩张、家庭治疗解决方案需求的不断增长以及积极采用本地製造策略。多样化的报销制度和劳动力考量凸显了製定针对特定区域的商业化和实施计画的必要性。

腹膜透析领域的竞争态势体现在专业设备製造商、解决方案製定者、契约製造以及新兴数位医疗参与企业的混合竞争。领先的产品开发商持续投资于週期计自动化、感测器整合以及面向患者的应用,以实现远端监控和依从性支援。同时,解决方案创新者则专注于改善生物相容性、减轻代谢负担、保护腹膜功能并延长治疗寿命。

随着现有企业寻求扩大产品组合,新进业者寻求更快扩张,策略伙伴关係、分销联盟和选择性收购变得司空见惯。製造外包和外包已成为控製成本和加快上市时间的重要槓桿,尤其是在关税波动和原材料限制影响生产经济效益的情况下。整合临床培训、供应物流和数位化跟进的公司能够在总护理成本和患者治疗效果方面实现差异化。最后,私募股权和企业投资者仍然活跃于该领域,他们被耗材带来的可预测的经常性收益以及临床对家庭护理日益增长的关注所吸引。

製造商、医疗保健提供者和购买者应采取的策略行动,以促进家庭腹膜透析解决方案的弹性、临床价值和采用

应对复杂腹膜透析环境的行业领导者应采取多管齐下的策略,将产品创新与营运韧性和付款人参与度相结合。首先,优先开发能够减轻临床医生负担并提升患者便利性的产品,例如週期计自动化、简化的连接系统以及膜保存解决方案。同时,透过多元化供应商、考虑近岸外包关键零件以及将关税意外事件纳入采购合同,增强供应链韧性并降低政策变化带来的风险。

同样重要的是建立强有力的临床证据,证明关键治疗领域和应用的疗效和成本效益。投资结合远端监控、临床医生支援和病患教育的试点项目,检验实际影响并支持报销讨论。与付款人和医疗系统建立伙伴关係,试行基于价值的合约模式,以奖励减少住院率并提高生活品质。最后,透过开发针对家庭医疗保健提供者的专业管道并培养临床团队来支援分散式照护路径,增强您的商业性能力。这些综合行动将使您能够在持续的政策和供应链不确定性中获得长期价值并保护净利率。

结合从业者访谈、政策分析和数据三角测量的强大混合方法为腹膜透析提供了有效且可操作的见解。

这些见解背后的研究结合了初步质性访谈、二手文献整合和比较政策分析,以确保获得稳健的三角测量结果。初步资讯包括与肾臟科医师、透析护理师、采购负责人、设备工程师和负责人进行结构化讨论,以了解临床工作流程、采购需求和报销考量。二级资讯来源包括同行评审的临床文献、监管指导文件、技术产品规范和公共声明,以确定临床和商业性趋势。

数据合成采用交叉验证技术,以协调不同的观点,并识别技术采用、供应链策略和区域政策反应的一致模式。情境映射用于探索资费调整和报销变化的潜在结果,敏感度分析则检验了策略建议在各种营运约束条件下的适应性。品质保证包括由临床和商业专家进行的同行评审,以确认事实的准确性和有效性。这种混合方法确保结论是基于从业者经验,并经过客观文献证据的检验。

简要总结扩大临床有效且操作灵活的腹膜透析计划所需的策略要点和相关人员协调。

摘要:腹膜透析正处于技术、政策和护理服务偏好交会的曲折点,这不仅带来了重大机会,也带来了营运挑战。自动化和溶液生物相容性的进步使家庭治疗更加可行,也更具临床吸引力,但不断变化的贸易政策和供应链的脆弱性要求我们采取积极的缓解策略。相关人员,将最有能力满足不断增长的临床需求,同时保护净利率。

随着临床界持续优先考虑以患者为中心的门诊护理模式,能否证明其改善的疗效、成本效益和营运可靠性将决定哪些解决方案能够被广泛采用。因此,製造商、医疗保健提供者、付款人和监管机构之间的合作对于实现扩充性、可及和永续的腹膜透析项目至关重要。这个结论强调,在我们迈入医疗保健转型的下一阶段时,策略敏捷性、临床严谨性和相关人员协作至关重要。

目录

第一章:前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 远端患者监护和远端医疗平台的普及可以提高药物依从性和治疗效果
  • 越来越多地转向整合人工智慧辅助处方调整的自动化家庭护理系统
  • 开发具有中性 pH 值和减少葡萄糖降解产物的生物相容性腹膜透析溶液,以提高患者的舒适度
  • 增加对新导管设计和植入式端口系统的投资,以最大限度地降低感染率并改善患者体验
  • 穿戴式装置和连续流技术的进步旨在减轻治疗负担并提高生活品质
  • 成本优势和本地培训倡议推动新兴市场腹膜透析计画的扩展,以减轻慢性肾臟病的负担
  • 整合数据分析和数位健康工具,实现个人化处方笺优化和风险分层模型
  • 游戏化病患教育和支援平台旨在提高腹膜透析治疗中的药物依从性和自我护理

第六章:2025年美国关税的累积影响

第七章:人工智慧的累积影响,2025年

8. 腹膜透析市场(依产品类型)

  • 配件
    • 腹膜透析液袋
    • 引流袋
    • 腹膜透析导管套件
    • 传输集
  • PD机
    • 自动腹膜透析週期计
    • 持续性非卧床腹膜透析
  • 腹腔液
    • 生物相容性解决方案
    • 葡萄糖溶液
    • 低糖溶液

9. 按治疗领域分類的腹膜透析市场

  • 急性肾损伤
  • 慢性肾臟病
  • 郁血性心臟衰竭

第 10 章腹膜透析市场:依应用

  • 糖尿病肾臟病
  • 肾丝球肾炎
  • 狼疮性肾炎
  • 多囊肾

第 11 章腹膜透析市场(依最终用户)

  • 透析中心
  • 家庭医疗保健
  • 医院

第十二章 腹膜透析市场(按地区)

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章腹膜透析市场(依类别)

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各国腹膜透析市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Advin Health Care
    • Angiplast Pvt. Ltd.
    • B. Braun Medical Ltd
    • Baxter International, Inc.
    • Becton, Dickinson and Company
    • Cook Group Incorporated
    • Diaverum AB by M42
    • Fresenius Medical Care AG
    • Huaren Pharmaceutical Co., Ltd.
    • JDmeditech
    • JMS Co., Ltd.
    • Medionics International Inc.
    • Mitra Industries
    • Mozarc Medical
    • Opterion Health AG
    • PFM Medical, Inc.
    • Renax Biomedical Technology Co., Ltd.
    • Renfrew Group International
    • Romsons Prime Private limited
    • Terumo Corporation
    • Toray Industries, Inc.
    • Vivance
Product Code: MRR-030EE485159D

The Peritoneal Dialysis Market is projected to grow by USD 15.83 billion at a CAGR of 6.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 9.86 billion
Estimated Year [2025] USD 10.43 billion
Forecast Year [2032] USD 15.83 billion
CAGR (%) 6.09%

Foundational overview of evolving care models, technology progress, and clinical priorities reshaping peritoneal dialysis delivery across clinical and home settings

Peritoneal dialysis remains a vital modality within renal replacement therapy, driven by changing patient demographics, care-delivery preferences, and continuous technological refinement. Over the past decade, clinicians and health systems have increasingly recognized the potential of peritoneal dialysis to support home-based care pathways, reduce inpatient exposure, and offer patient-centered autonomy. These shifts have been reinforced by innovations in cycler automation, improvements in solution biocompatibility, and integrated remote monitoring capabilities that together lower barriers to outpatient management.

Consequently, stakeholders from device manufacturers and solution formulators to dialysis providers and payers are reassessing clinical protocols, supply chains, and training models to align with evolving practice patterns. Clinicians emphasize preserving peritoneal membrane function and simplifying therapy regimens to improve adherence, while health systems focus on value-based outcomes and operational efficiencies. As a result, product roadmaps and strategic investments increasingly prioritize durability, connectivity, and ease of use. This introductory overview sets the foundation for a focused examination of drivers, constraints, and strategic levers that affect adoption and innovation within peritoneal dialysis moving forward.

How converging advances in automation, solution chemistry, remote monitoring, and policy incentives are redefining peritoneal dialysis care models and supply priorities

The landscape of peritoneal dialysis is undergoing transformative shifts driven by converging forces in technology, care delivery, and policy. On the technology front, automation has advanced from basic cycler functionality to intelligent systems that reduce manual steps and support adherence through scheduling, alerts, and remote data transmission. Meanwhile, solution chemistry has progressed toward formulations that reduce peritoneal membrane stress and lower complication risk, enabling longer-term therapy viability.

Simultaneously, the care-delivery paradigm is shifting toward decentralization: more patients are being managed at home with structured clinical oversight conducted remotely. This transition has catalyzed investment in telehealth-enabled monitoring, integrated supply logistics, and patient education platforms. Policy and reimbursement frameworks in several jurisdictions are adapting to incentivize home therapies, though heterogeneity remains across payers. Finally, supply chain resilience and supplier diversification have become strategic priorities after recent disruptions, prompting manufacturers to reassess sourcing, contract terms, and nearshoring options. Together, these shifts create both opportunities for differentiation and new operational challenges for manufacturers, providers, and health systems.

Assessment of evolving procurement dynamics and manufacturer strategies in response to 2025 tariff shifts that influence cost, sourcing, and service continuity

The introduction of new tariff measures in 2025 has injected additional complexity into procurement and supply chain planning for peritoneal dialysis stakeholders. Increased duties on imported consumables and capital equipment have pressured cost structures for providers and manufacturers that rely on global sourcing of bags, connectors, and cycler components. In response, some suppliers have accelerated diversification of manufacturing footprints, prioritized local sourcing of critical raw materials, and revisited supplier consolidation strategies to mitigate exposure to trade policy volatility.

These developments have also prompted health systems and purchasing groups to renegotiate long-term supply agreements, incorporate tariff contingency clauses into contracts, and evaluate total landed cost rather than unit price alone. At the same time, accelerated interest in domestic manufacturing capacities and strategic stockpiling has emerged as a buffer against future tariff-driven disruptions. Regulatory agencies and payers are increasingly attentive to how cost pressures may affect access and utilization patterns, fueling dialogue on reimbursement adjustments and value-based contracting. The net effect is a more complex procurement environment where operational agility, scenario planning, and supplier ecosystem resilience are essential to maintain continuity of peritoneal dialysis services.

Deep-dive segmentation insights connecting product portfolios, therapeutic indications, clinical applications, and end-user requirements to strategic priorities

Insights drawn from product, therapeutic, application, and end-user segmentation reveal differentiated opportunities and constraints across the peritoneal dialysis ecosystem. By product type, the space encompasses accessories-for example, bags for peritoneal dialysis solutions, drainage bags, peritoneal dialysis catheter kits, and transfer sets-alongside PD machines such as automated peritoneal dialysis cyclers and continuous ambulatory peritoneal dialysis devices, and a range of peritoneal solutions including biocompatible solutions, glucose-based solutions, and low-glucose solutions. These product distinctions directly affect procurement cycles, clinical training needs, and capital investment decisions, with consumables driving recurring logistics priorities and capital devices influencing clinical workflow redesign.

By therapeutic area, the therapy serves acute kidney injury, chronic kidney disease, and congestive heart failure populations, each with unique clinical trajectories and utilization patterns that inform device selection and solution choice. From an application perspective, managing etiologies such as diabetic nephropathy, glomerulonephritis, lupus nephritis, and polycystic kidney disease requires tailored clinical protocols and distinct monitoring strategies. End users vary from dialysis centers to home healthcare programs and hospitals, and each setting imposes different requirements for staff training, inventory management, and remote support. Integrating these segmentation lenses provides a granular view for prioritizing R&D, commercial channels, and clinical evidence generation.

Comparative view of how regional payer frameworks, clinical practice variation, and manufacturing footprints shape adoption and access across global peritoneal dialysis markets

Regional dynamics materially shape technology adoption, regulatory pathways, and care-delivery models across the peritoneal dialysis landscape. In the Americas, clinicians and providers are balancing strong clinical interest in home-based therapies with payer-driven imperatives for demonstrable outcomes and cost containment, creating fertile ground for value propositions that combine improved patient experience with measurable reductions in hospital utilization. Regulatory clarity and established reimbursement mechanisms in certain markets accelerate adoption, but disparities exist across subnational payers.

Across Europe, the Middle East & Africa, the landscape is heterogeneous: Western European markets demonstrate advanced clinical protocols and growing telehealth integration, while other territories contend with infrastructure constraints and variable access to consumables. Policymakers and health systems in the region increasingly prioritize supply chain resilience and equitable access, prompting innovative public-private partnerships. In the Asia-Pacific region, rapid growth in chronic kidney disease prevalence is intersecting with expanding healthcare infrastructure, rising demand for home therapy solutions, and active adoption of local manufacturing strategies. Diverse reimbursement regimes and workforce considerations underscore the need for region-specific commercialization and implementation plans.

Competitive dynamics in peritoneal dialysis are characterized by a mix of specialized device manufacturers, solution formulators, contract manufacturers, and emerging digital health entrants. Leading product developers continue to invest in cycler automation, sensor integration, and patient-facing applications that enable remote monitoring and adherence support. At the same time, solution innovators are focused on improving biocompatibility and reducing metabolic burden to preserve peritoneal membrane function and extend therapy longevity.

Strategic partnerships, distribution alliances, and selective acquisitions are common as established players seek to broaden portfolios and newcomers aim to scale more rapidly. Contract manufacturing and outsourcing have become important levers to manage cost and accelerate time to market, particularly where tariff dynamics or raw material constraints affect production economics. Service and support models are also evolving: companies that integrate clinical training, supply logistics, and digital follow-up can differentiate around total cost of care and patient outcomes. Finally, private equity and corporate investors remain active in the space, drawn to predictable recurring revenue from consumables and the growing clinical emphasis on home-based therapies.

Actionable strategic moves for manufacturers, providers, and purchasers to advance resilience, clinical value, and adoption of home-focused peritoneal dialysis solutions

Industry leaders seeking to navigate the complex peritoneal dialysis environment should adopt a multi-dimensional strategy that aligns product innovation with operational resilience and payer engagement. First, prioritize product development that reduces clinician burden and enhances patient usability, including cycler automation, simplified connection systems, and solutions engineered for membrane preservation. Simultaneously, strengthen supply chain resilience by diversifying supplier bases, considering nearshoring for critical components, and embedding tariff contingencies into procurement contracts to reduce exposure to policy shifts.

Equally important is to build robust clinical evidence demonstrating outcomes and cost-effectiveness tailored to key therapeutic segments and applications. Invest in pilot programs that combine remote monitoring, clinician support, and patient education to validate real-world benefits and support reimbursement discussions. Forge partnerships with payers and health systems to pilot value-based contracting models that align incentives around reduced hospitalization and enhanced quality of life. Finally, enhance commercial capabilities by developing specialized channels for home healthcare providers and by training clinical teams to support decentralized care pathways. These combined actions will position organizations to capture long-term value while protecting margins amid ongoing policy and supply-chain uncertainty.

Robust mixed-methods approach combining practitioner interviews, policy analysis, and data triangulation to deliver validated and actionable peritoneal dialysis insights

The research underpinning these insights integrates primary qualitative interviews, secondary literature synthesis, and comparative policy analysis to ensure robust, triangulated findings. Primary inputs include structured discussions with nephrologists, dialysis nurses, procurement officers, device engineers, and payer representatives to capture clinical workflows, procurement imperatives, and reimbursement considerations. Secondary sources comprised peer-reviewed clinical literature, regulatory guidance documents, technical product specifications, and public policy statements, which together contextualize clinical and commercial trends.

Data synthesis employed cross-validation techniques to reconcile divergent perspectives and identify consistent patterns in technology adoption, supply chain strategies, and regional policy responses. Scenario mapping was used to explore potential outcomes of tariff shifts and reimbursement changes, while sensitivity analyses tested the resilience of strategic recommendations under different operational constraints. Quality assurance included peer review by clinical and commercial experts to confirm factual accuracy and relevance. This mixed-methods approach ensures that conclusions are grounded in practitioner experience and validated against objective documentary evidence.

Concise synthesis of strategic imperatives and stakeholder alignments required to scale clinically effective and operationally resilient peritoneal dialysis programs

In summary, peritoneal dialysis stands at an inflection point where technology, policy, and care-delivery preferences intersect to create both significant opportunities and operational challenges. Advances in automation and solution biocompatibility are making home-based therapy more feasible and clinically attractive, yet trade policy shifts and supply chain vulnerabilities necessitate proactive mitigation strategies. Stakeholders that align product development with service models, invest in clinical evidence, and adopt resilient sourcing practices will be best positioned to meet growing clinical demand while protecting margins.

As the clinical community continues to emphasize patient-centered, outpatient care models, the ability to demonstrate improved outcomes, cost-effectiveness, and operational reliability will determine which solutions gain broad adoption. Therefore, collaboration across manufacturers, providers, payers, and regulators is essential to enable scalable, accessible, and sustainable peritoneal dialysis programs. The conclusion reinforces the imperative for strategic agility, clinical rigor, and stakeholder alignment as the sector advances into the next phase of care transformation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of remote patient monitoring and telehealth platforms to improve peritoneal dialysis adherence and outcomes
  • 5.2. Increasing shift toward home-based automated peritoneal dialysis systems with integrated AI-driven prescription adjustments
  • 5.3. Development of biocompatible peritoneal dialysis solutions with neutral pH and reduced glucose degradation products to enhance patient comfort
  • 5.4. Growing investment in novel catheter designs and implantable port systems to minimize infection rates and improve patient experience
  • 5.5. Advances in wearable peritoneal dialysis devices and continuous flow technologies aiming to reduce treatment burden and enhance quality of life
  • 5.6. Expansion of peritoneal dialysis programs in emerging markets driven by cost advantages and localized training initiatives to address chronic kidney disease burden
  • 5.7. Integration of data analytics and digital health tools for personalized peritoneal dialysis prescription optimization and risk stratification models
  • 5.8. Implementation of patient education and support platforms leveraging gamification to boost adherence and self-care in peritoneal dialysis therapy

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peritoneal Dialysis Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Bags for PD solutions
    • 8.1.2. Drainage bags
    • 8.1.3. Peritoneal Dialysis Catheter Kit
    • 8.1.4. Transfer sets
  • 8.2. PD Machines
    • 8.2.1. Automated Peritoneal Dialysis Cycler
    • 8.2.2. Continuous Ambulatory Peritoneal Dialysis
  • 8.3. Peritoneal Solution
    • 8.3.1. Biocompatible solutions
    • 8.3.2. Glucose-based solutions
    • 8.3.3. Low-glucose solutions

9. Peritoneal Dialysis Market, by Therapeutic Area

  • 9.1. Acute Kidney Injury
  • 9.2. Chronic Kidney Disease
  • 9.3. Congestive Heart Failure

10. Peritoneal Dialysis Market, by Application

  • 10.1. Diabetic Nephropathy
  • 10.2. Glomerulonephritis
  • 10.3. Lupus Nephritis
  • 10.4. Polycystic Kidney Disease

11. Peritoneal Dialysis Market, by End User

  • 11.1. Dialysis Centers
  • 11.2. Home Healthcare
  • 11.3. Hospitals

12. Peritoneal Dialysis Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Peritoneal Dialysis Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Peritoneal Dialysis Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Advin Health Care
    • 15.3.2. Angiplast Pvt. Ltd.
    • 15.3.3. B. Braun Medical Ltd
    • 15.3.4. Baxter International, Inc.
    • 15.3.5. Becton, Dickinson and Company
    • 15.3.6. Cook Group Incorporated
    • 15.3.7. Diaverum AB by M42
    • 15.3.8. Fresenius Medical Care AG
    • 15.3.9. Huaren Pharmaceutical Co., Ltd.
    • 15.3.10. JDmeditech
    • 15.3.11. JMS Co., Ltd.
    • 15.3.12. Medionics International Inc.
    • 15.3.13. Mitra Industries
    • 15.3.14. Mozarc Medical
    • 15.3.15. Opterion Health AG
    • 15.3.16. PFM Medical, Inc.
    • 15.3.17. Renax Biomedical Technology Co., Ltd.
    • 15.3.18. Renfrew Group International
    • 15.3.19. Romsons Prime Private limited
    • 15.3.20. Terumo Corporation
    • 15.3.21. Toray Industries, Inc.
    • 15.3.22. Vivance

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. PERITONEAL DIALYSIS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. PERITONEAL DIALYSIS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PERITONEAL DIALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BAGS FOR PD SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BAGS FOR PD SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BAGS FOR PD SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BAGS FOR PD SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BAGS FOR PD SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BAGS FOR PD SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DRAINAGE BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DRAINAGE BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DRAINAGE BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DRAINAGE BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DRAINAGE BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DRAINAGE BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS CATHETER KIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS CATHETER KIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS CATHETER KIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS CATHETER KIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS CATHETER KIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS CATHETER KIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY TRANSFER SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY TRANSFER SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY TRANSFER SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY TRANSFER SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY TRANSFER SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY TRANSFER SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS CYCLER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS CYCLER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS CYCLER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS CYCLER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS CYCLER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS CYCLER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BIOCOMPATIBLE SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BIOCOMPATIBLE SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BIOCOMPATIBLE SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BIOCOMPATIBLE SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BIOCOMPATIBLE SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BIOCOMPATIBLE SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLUCOSE-BASED SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLUCOSE-BASED SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLUCOSE-BASED SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLUCOSE-BASED SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLUCOSE-BASED SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLUCOSE-BASED SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LOW-GLUCOSE SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LOW-GLUCOSE SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LOW-GLUCOSE SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LOW-GLUCOSE SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LOW-GLUCOSE SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LOW-GLUCOSE SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACUTE KIDNEY INJURY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACUTE KIDNEY INJURY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACUTE KIDNEY INJURY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACUTE KIDNEY INJURY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLOMERULONEPHRITIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLOMERULONEPHRITIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLOMERULONEPHRITIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLOMERULONEPHRITIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLOMERULONEPHRITIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLOMERULONEPHRITIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LUPUS NEPHRITIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LUPUS NEPHRITIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LUPUS NEPHRITIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LUPUS NEPHRITIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LUPUS NEPHRITIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LUPUS NEPHRITIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. GCC PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. GCC PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. GCC PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. GCC PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. GCC PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 304. GCC PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 305. GCC PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 306. GCC PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 307. GCC PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 308. GCC PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 309. GCC PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 310. GCC PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 311. GCC PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. GCC PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 313. GCC PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. GCC PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE,